Journal of Pediatric Neurology 2012; 10(04): 313-316
DOI: 10.3233/JPN-120573
Case Report
Georg Thieme Verlag KG Stuttgart – New York

Cyclosporine-induced PRES in a child recipient of allogeneic bone marrow transplantation

Omar M. Chamdine
a   Department of Pediatric Hematology Oncology, Makassed General Hospital, Beirut, Lebanon
,
Abdul-Rahman S. Shatila
b   Department of Neurology, Makassed General Hospital, Beirut, Lebanon
,
Nabil A. Yassin
a   Department of Pediatric Hematology Oncology, Makassed General Hospital, Beirut, Lebanon
,
Samar A. Muwakkit
c   Department of Pediatrics, Children's Cancer Center of Lebanon, American University of Beirut, Beirut, Lebanon
,
Ahmad O. Ibrahim
d   Department of Internal Medicine, Division of Hematology Oncology, Makassed General Hospital, Beirut, Lebanon
› Author Affiliations

Subject Editor:
Further Information

Publication History

11 May 2011

13 November 2011

Publication Date:
30 July 2015 (online)

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a recently described clinic-radiological entity. It has been associated with a number of medical conditions, such as eclampsia, arterial hypertension, renal failure, and vasculitis. Drugs causing immunosuppression such as cyclosporine A, tacrolimus, cancer chemotherapy, and steroids have been implicated in the etiology of PRES. Its pathogenesis remains poorly understood. Clinical findings are not sufficiently specific; however, neuroimaging is often characteristic. Few cases of PRES were reported in children who were treated for cancer, most of whom had acute lymphoblastic leukemia. This case-report describes PRES following allogeneic bone marrow transplantation in a child with acute lymphocytic leukemia.